Results 131 to 140 of about 21,888 (191)

Intravascular brachytherapy vs. drug-coated balloons for in-stent restenosis in patients with diabetes. [PDF]

Front Cardiovasc Med
Sella G, Gandelman G, Blatt A, George J, Abu Khadija H, Ayyad O, Olek D, Teh BS, Lin YY, Deva A, Kharsa C, Kritya M, Anwaar MF, Elias J, El Hajj E, Raizner AE, Farach A, Kleiman NS, Shah A.   +18 more
europepmc   +1 more source

Head-to-head comparison of limus- versus paclitaxel-coated balloons in the treatment of in-stent restenosis: a meta-analysis. [PDF]

AsiaIntervention
Sagris M, Soulaidopoulos S, Ktenopoulos N, Papanikolaou A, Dimitriadis K, Patsourakos N, Tousoulis D, Scheller B, Colombo A, Tsioufis K.   +9 more
europepmc   +1 more source

Remnant Cholesterol as a Predictor of Target-Vessel Failure in Patients With In-Stent Restenosis. [PDF]

Rev Cardiovasc Med
Kong XH, Lv ZH, Wang YF, Sun YD, Xu T, You W, Meng PN, Wu XQ, Wu ZM, Jia HB, Ye F.   +10 more
europepmc   +1 more source

The impact of metabolic syndrome and triglyceride-glucose index on the risk of in-stent restenosis after percutaneous coronary intervention: a retrospective study. [PDF]

Front Cardiovasc Med
Han L, Chen Y, Xu L, Chen W.
europepmc   +1 more source

Immune dysregulation complicated by recurrent in-stent restenosis in patients with multivessel coronary artery disease: a case report. [PDF]

BMC Cardiovasc Disord
Jiang J, Huang Z, Li C, Zhang H, Zhao Z, Yang F, Gai Y, Li F, Gong C, Wu Y.   +9 more
europepmc   +1 more source

The association between glycated hemoglobin levels and in-stent restenosis following percutaneous coronary intervention in coronary artery disease patients. [PDF]

Front Endocrinol (Lausanne)
Lei Y, Jin P, Liu H, Su L, Wu D, Sun C, Wu H, Zhou J, Wang C.   +8 more
europepmc   +1 more source

Reply to Letter to the Editor: "Comments on 'Evaluation of Whole Blood Viscosity to Predict Stent Restenosis'". [PDF]

Anatol J Cardiol
Çalapkulu Y.
europepmc   +1 more source

Outcomes of Drug-Coated Balloon Versus Drug-Eluting Stent for In-Stent Restenosis and De-Novo Lesions: A Meta-Analysis of Randomized Controlled Trials. [PDF]

Health Sci Rep
Moghadam AS, Kazemian S, Shojaei S, Moghadam SS, Dolama RH, Ebrahimi R, Shirmard FO, Pourfaraji SMA, Najafi MS, Hobaby S, Soleimani H, Tajdini M, Tehrani B, Kolte D, Elgendy I, Basavarajaiah S, Latib A, Sattar Y, Chadi Alraies M, Hosseini K.   +19 more
europepmc   +1 more source

Research progress on risk factors for in-stent restenosis following cerebrovascular stent implantation. [PDF]

Front Neurol
Gao H, Bibi H, Tan H, Zhang Y, Yang G, Wang J, Wu T.   +6 more
europepmc   +1 more source

Drug-coated balloons in coronary in-stent restenosis: a systematic review and meta-analysis comparing sirolimus and biolimus with paclitaxel platforms. [PDF]

Cardiovasc Interv Ther
Dandamudi M, Faizan MA, Rehman T, Lecchi C, Ghimire M, Inampudi JV, Mojica JC, Chamay S, Giorgi J.   +8 more
europepmc   +1 more source